HRES 309
Expressing the sense of the House of Representatives that the Food and Drug Administration has the authority to approve drugs for abortion care.
Take action
Record your position on this measure.
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
This House Resolution affirms that the Food and Drug Administration (FDA) has the authority to approve drugs, including those used in medication abortion like mifepristone. It argues that recent court decisions attempting to restrict the FDA’s approval of mifepristone are inconsistent with Congress’s intent regarding the FDA’s role in drug regulation. The resolution emphasizes the FDA’s expertise and the importance of protecting access to reproductive healthcare options.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Kathy E. Manning
Cosponsors
Becca [D-VT-At Large] Balint
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.